PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.71
−8.88%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.80
From 52W high−89.21%
Volume77431.00
Market cap$2.49M
P/E (TTM)—
P/S (TTM)63.1x
Div yield—
Key dataOct 19, 2026
Open
$0.80
From 52W high
−89.21%
Volume
77431.00
Market cap
$2.49M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.1x
P/E (TTM)
—
RSI (14)
27.9
MomentumView details →
1D Return
−8.88%
YTD Return
−77.18%
SummaryUpdated Jun 1, 2026
PainReform Ltd. (NASDAQ:PRFX) is a clinical-stage specialty pharmaceutical company founded in 2007 and based in Tel Aviv, Israel. The company went public in September 2020 and focuses on developing innovative pain management therapeutics specifically designed to provide extended post-surgical pain relief. PainReform is currently advancing its lead product candidate through late-stage clinical trials, positioning itself in the specialized field of localized post-operative pain management.
Similar companies
Latest newsMore news →
No recent news for PRFX.